Laurel A. Menapace/LinkedIn
Aug 2, 2026, 09:04
Laurel A. Menapace: Investing in the Next Generation of Hematology Leaders
Laurel A. Menapace, Former Senior Clinical Research Director of Rare Blood Disorders, Fitusiran Development Program at Sanofi, shared a post on LinkedIn:
“Thoroughly enjoyed participating in ISTH’s ECC Networking with Industry Session.
Some of the best career advice I’ve received has come from people willing to share their experiences openly.
I’m grateful for the opportunity to pay that forward and discuss career paths, clinical development, industry partnerships, and the many ways we can continue advancing therapies for patients.
Building the future of hematology requires more than great science—it requires investing in the people who will lead it.”
Stay updated with Hemostasis Today.
-
Aug 2, 2026, 23:07Akshat Jain: Redefining Hemophilia Readiness in Mexico
-
Aug 2, 2026, 16:24Satish Medakkar: The Importance of Early Recognition in Atypical Hemolytic Uremic Syndrome
-
Aug 2, 2026, 16:07Mirjavad Mammadov: Understanding the Thrombotic Paradox of Heparin Therapy
-
Aug 2, 2026, 15:49Munira Borhany: Advancing Equity in Women’s Hematological Care
-
Aug 2, 2026, 14:54Every Second Counts: How CPR and AEDs Can Save a Life – American Heart Association
-
Aug 2, 2026, 14:38New French Guidelines for Acquired Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Aug 2, 2026, 14:36Sankesh Mehta: Restoring Venous Patency Through Mechanical Thrombectomy
-
Aug 2, 2026, 14:17Douglas Tavares: How Do We Get More People To Donate?
-
Aug 2, 2026, 14:15Saleh Shamse Basha: Severe Neonatal Anemia – When the Analyzer Tells a Story Before the Slide Does